Efficacy and safety of mufemilast in patients with Behçet’s syndrome: a phase 2 randomised clinical trial

Journal:

Annals of the Rheumatic Diseases

Published:

2026-02-26

DOI:

10.1016/j.ard.2026.01.014

Affiliations:

27

Authors:

34

Go to article

Institutions	Authors	Share
Peking University People's Hospital, PKUHSC, China	3.000000	0.09
Hemay Pharmaceutical, China	2.000000	0.06
Sun Yat-sen Memorial Hospital, SYSU, China	2.000000	0.06
The First Affiliated Hospital, Zhejiang University School of Medicine, China	2.000000	0.06
Affiliated Hospital, XZMC, China	2.000000	0.06
Jilin Province People's Hospital, China	2.000000	0.06
Huashan Hospital, Fudan University, China	2.000000	0.06
Tongji Hospital, Tongji University, China	1.000000	0.03
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.03
Beijing Hospital, China	1.000000	0.03
Xuanwu Hospital, Capital Medical University, China	1.000000	0.03
Peking University First Hospital, PKUHSC, China	1.000000	0.03
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	1.000000	0.03
People's Hospital of Xinjiang Uygur Autonomous Region, China	1.000000	0.03
The First Affiliated Hospital of Soochow University, China	1.000000	0.03
First Affiliated Hospital, ZZU, China	1.000000	0.03
The First Affiliated Hospital, USTC, China	1.000000	0.03
The First Affiliated Hospital of Wenzhou Medical University, China	1.000000	0.03
Zhejiang Provincial People's Hospital, China	1.000000	0.03
The First Affiliated Hospital of Xiamen University, China	1.000000	0.03
Peking Union Medical College Hospital (PUMCH), China	1.000000	0.03
The University of Hong Kong - Shenzhen Hospital (HKU-SZH), China	1.000000	0.03
Zhongshan Hospital, Fudan University, China	1.000000	0.03
Linyi People's Hospital, China	1.000000	0.03
China-Japan Union Hospital of Jilin University, JLU, China	1.000000	0.03
First Hospital Affiliated to Baotou Medical College, IMUST, China	1.000000	0.03

Interested in Clinical Sciences?